Michael Bernstein, MD is a clinical research site located in Birmingham, Alabama, United States 35216.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Michael Bernstein, MD has participated in 1 clinical trials.
Therapeutic areas: Keratoconjunctivitis Sicca.
Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc..
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Michael Bernstein, MD has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Michael Bernstein, MD has 1 clinical trials on record. Their work covers Keratoconjunctivitis Sicca.
Michael Bernstein, MD has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.